Retraction

Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway

Paper Information

Record ID:

64719

Author(s):

Guobing Li
Changyu Shan
Lei Liu
Ting Zhou
Jing Zhou
Xiaoye Hu
Yibiao Chen
Hongjuan Cui
Ning Gao

Journal:

PLoS One ( PLoS )

Publication Date:

February 06, 2015

Retraction Date:

March 21, 2025 (<1 year years ago)

Subjects:

Broad Categories:
Medicine Biology Genetics

Specific Fields:
Biology - Cancer Genetics Medicine - Obstetrics/Gynecology Medicine - Oncology

Institutions:

Country:

🇨🇳 China

Article Type:

Research Article

Publisher:

PLoS

Open Access:

Yes

DOI:

10.1371/journal.pone.0117440

PubMed ID:

25659153

Retraction PubMed ID:

40117527

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction

Retraction Notice:

10.1371/journal.pone.0321151

Citations (92)

92

Total Citations

1

Post-Retraction
(1.1%)

90

Pre-Retraction

1

Same Day

Post-Retraction Citation Analysis

0 Within 30 days

1 Within 1 year

0 After 2+ years

52 Days since retraction (latest)

Correction: Retraction: Tanshinone IIA Inhibits HIF-1α and VEGF Expression in Breast Cancer Cells via mTOR/p70S6K/RPS6/4E-BP1 Signaling Pathway

Unknown Authors

PLoS ONE Open Access

Published: May 2025

52 days after retraction

Retraction: Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway

Unknown Authors

PLoS ONE Open Access

Published: Mar 2025
1 citation

Same day as retraction

Cytotoxic Effects of Plant Secondary Metabolites and Naturally Occurring Bioactive Peptides on Breast Cancer Model Systems: Molecular Mechanisms

Diana Zasheva, Petko Mladenov, Silvina Zapryanova et al. (10 authors)

Molecules Open Access

Published: Nov 2024
4 citations

134 days before retraction

Tanshinone II A Facilitates Chemosensitivity of Osteosarcoma Cells to Cisplatin via Activation of p38 MAPK Pathway

D Xie, Zhi-yun Li, Bing Ren et al. (6 authors)

Chinese Journal of Integrative Medicine

Published: Nov 2024

136 days before retraction

Management of triple-negative breast cancer by natural compounds through different mechanistic pathways

Mohammed Kaleem, Mandar A. Thool, Nitin G. Dumore et al. (9 authors)

Frontiers in Genetics Open Access

Published: Jul 2024
5 citations

238 days before retraction

Homologous-magnetic dual-targeted metal-organic framework to improve the Anti-hepatocellular carcinoma efficacy of PD-1 inhibitor

Hong Guo, Xia Li, Dengxuan Mao et al. (10 authors)

Journal of Nanobiotechnology Open Access

Published: Apr 2024
6 citations

331 days before retraction

Homologous-Magnetic Dual-Targeted Metal-Organic Framework to Improve the Anti-Hepatocellular Carcinoma Efficacy of PD-1 Inhibitor

Hong Guo, Xia Li, Dengxuan Mao et al. (10 authors)

Research Square (Research Square) Open Access

Published: Feb 2024

407 days before retraction

Preclinical Characterization of 22-(4′-Pyridinecarbonyl) Jorunnamycin A against Lung Cancer Cell Invasion and Angiogenesis via AKT/mTOR Signaling

Iksen Iksen, Suthasinee Seephan, Vudhiporn Limprasutr et al. (7 authors)

ACS Pharmacology & Translational Science

Published: Jul 2023
3 citations

605 days before retraction

Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapy

Syed Sahajada Mahafujul Alam, Arijit Samanta, Faizan Uddin et al. (5 authors)

Pharmacological Reports

Published: Jul 2023
11 citations

617 days before retraction

Current Drugs and their Therapeutic Targets for Hypoxia-inducible Factors in Cancer

Esha Joshi, Medha Pandya, Urja Desai

Current Protein and Peptide Science

Published: Jun 2023
3 citations

658 days before retraction

New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis

Xin Li, Jianbo Zhou, Xue Wang et al. (7 authors)

Biomedicine & Pharmacotherapy Open Access

Published: May 2023
19 citations

683 days before retraction

Potential Phytochemicals for Prevention of Familial Breast Cancer with BRCA Mutations

Aliasgar Shahiwala, Gazala Afreen Khan

Current Drug Targets

Published: Mar 2023
5 citations

737 days before retraction

Compounds from diverse natural origin against triple‐negative breast cancer: A comprehensive review

Ramasamy Thilagavathi, Sridhar Priyankha, Manivel Kannan et al. (5 authors)

Chemical Biology & Drug Design

Published: Nov 2022
10 citations

869 days before retraction

Salvia miltiorrhiza in cancer: Potential role in regulating MicroRNAs and epigenetic enzymes

Lu Meng, Xintian Lan, Xi Wu et al. (8 authors)

Frontiers in Pharmacology Open Access

Published: Sep 2022
7 citations

921 days before retraction

Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition

Supawan Jampasri, Somrudee Reabroi, Duangjai Tungmunnithum et al. (5 authors)

Molecules Open Access

Published: Sep 2022
13 citations

928 days before retraction

Molecular Mechanism of Tanshinone against Prostate Cancer

Wěi Li, Tao Huang, Shenghan Xu et al. (7 authors)

Molecules Open Access

Published: Aug 2022
16 citations

934 days before retraction

Advances on Natural Abietane, Labdane and Clerodane Diterpenes as Anti-Cancer Agents: Sources and Mechanisms of Action

Rosaria Acquaviva, Giuseppe Antonio Malfa, Monica Rosa Loizzo et al. (6 authors)

Molecules Open Access

Published: Jul 2022
33 citations

969 days before retraction

eEF‐2K knockdown synergizes with STS treatment to inhibit cell proliferation, migration, and invasion via the TG2/ERK pathway in A549 cells

Bu Wang, Xin Gu, Bao‐Li Xiang et al. (7 authors)

Journal of Biochemical and Molecular Toxicology

Published: Jul 2022
3 citations

978 days before retraction

Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology

Jianbo Zhou, Li Wang, Cheng Peng et al. (4 authors)

Frontiers in Pharmacology Open Access

Published: Jun 2022
24 citations

1010 days before retraction

Salvia miltiorrhiza in Breast Cancer Treatment: A Review of Its Phytochemistry, Derivatives, Nanoparticles, and Potential Mechanisms

Huan Zhao, Bing Han, Xuan Li et al. (10 authors)

Frontiers in Pharmacology Open Access

Published: May 2022
29 citations

1051 days before retraction

Tanshinone IIA inhibits cell growth by suppressing SIX1‑induced aerobic glycolysis in non‑small cell lung cancer cells

Hailiang Qi, Zhengyi Chen, Yuhuan Qin et al. (6 authors)

Oncology Letters Open Access

Published: Apr 2022
22 citations

1065 days before retraction

Role of Plant-Derived Active Constituents in Cancer Treatment and Their Mechanisms of Action

Abdul Waheed Khan, Mariya Farooq, Muhammad Haseeb et al. (4 authors)

Cells Open Access

Published: Apr 2022
42 citations

1073 days before retraction

Cryptotanshinone inhibits proliferation and induces apoptosis of breast cancer MCF-7 cells via GPER mediated PI3K/AKT signaling pathway

Danning Shi, Hongbo Li, Zeye Zhang et al. (7 authors)

PLoS ONE Open Access

Published: Jan 2022
19 citations

1155 days before retraction

Combined Effects of Tanshinone IIA and an Autophagy Inhibitor on the Apoptosis of Leukemia Cells via p53, Apoptosis-Related Proteins and Oxidative Stress Pathways

Ying Song, Cheng-Chieh Kuo, Chuan-Teng Liu et al. (6 authors)

Integrative Cancer Therapies Open Access

Published: Jan 2022
9 citations

1175 days before retraction

Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy

Mark J. de Keijzer, Daniel J. de Klerk, Lianne R. de Haan et al. (9 authors)

Methods in molecular biology

Published: Jan 2022
8 citations

1175 days before retraction

Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine

Wenfeng Zhang, Cun Liu, Jie Li et al. (9 authors)

The American Journal of Chinese Medicine

Published: Jan 2022
54 citations

1175 days before retraction

RNA‐binding proteins and translation control in angiogenesis

Madeleine Smith, Guilherme Costa

FEBS Journal Open Access

Published: Nov 2021
22 citations

1218 days before retraction

Anti-Cancer Activity of Phytochemicals Targeting Hypoxia-Inducible Factor-1 Alpha

Ba Da Yun, Seung Wan Son, Soo Young Choi et al. (6 authors)

International Journal of Molecular Sciences Open Access

Published: Sep 2021
23 citations

1288 days before retraction

Tanshinone IIA: A Review of its Anticancer Effects

Zhong-Ying Fang, Miao Zhang, Jia‐Ning Liu et al. (6 authors)

Frontiers in Pharmacology Open Access

Published: Jan 2021
100 citations

1527 days before retraction

Human Positive Coactivator 4 Affects the Progression and Prognosis of Pancreatic Ductal Adenocarcinoma via the mTOR/P70s6k Signaling Pathway

Xingxing Su, Yishi Yang, Le Ma et al. (13 authors)

OncoTargets and Therapy Open Access

Published: Nov 2020
5 citations

1601 days before retraction

Comparison of regulatory networks of E74‑like factor 1 and cold‑shock domain‑containing E1 in breast cancer cell lines using ChIP datasets

Haibo Duan, Huafang He, Qian Hu et al. (8 authors)

Experimental and Therapeutic Medicine Open Access

Published: Oct 2020
3 citations

1611 days before retraction

Phytochemicals as PI3K/ Akt/ mTOR Inhibitors and Their Role in Breast Cancer Treatment

Arunaksharan Narayanankutty

Recent Patents on Anti-Cancer Drug Discovery

Published: Sep 2020
21 citations

1652 days before retraction

Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases

Zhibei Li, Jing Zou, Dan Cao et al. (4 authors)

Biomedicine & Pharmacotherapy Open Access

Published: Aug 2020
49 citations

1676 days before retraction

An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen)

Irum Naz, Myriam Mérarchi, Shanaya Ramchandani et al. (8 authors)

Exploration of Targeted Anti-tumor Therapy Open Access

Published: Jun 2020
16 citations

1740 days before retraction

CCT020312 Inhibits Triple-Negative Breast Cancer Through PERK Pathway-Mediated G1 Phase Cell Cycle Arrest and Apoptosis

Xiaoli Li, Xiaoping Yu, Duanfang Zhou et al. (9 authors)

Frontiers in Pharmacology Open Access

Published: May 2020
22 citations

1767 days before retraction

Tanshinones and their Derivatives: Heterocyclic Ring-Fused Diterpenes of Biological Interest

Arturo Estolano-Cobián, Mariana Macías-Alonso, Laura Díaz-Rubio et al. (6 authors)

Mini-Reviews in Medicinal Chemistry

Published: Apr 2020
14 citations

1787 days before retraction

The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients

Li Fu, Bing Han, Yang Zhou et al. (8 authors)

Frontiers in Pharmacology Open Access

Published: Mar 2020
76 citations

1828 days before retraction

A study of zederone for the inhibition on ovarian cancer cell proliferation through mTOR/p70s6K signalling pathway.

Zhilei Zhang, Linyu Li, Junmin Wang et al. (8 authors)

Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: Mar 2020
2 citations

1846 days before retraction

Bayesian differential analysis of gene regulatory networks exploiting genetic perturbations

Yan Li, Dayou Liu, Tengfei Li et al. (4 authors)

BMC Bioinformatics Open Access

Published: Jan 2020
7 citations

1898 days before retraction

A Review of Natural Therapies Potentially Relevant in Triple Negative Breast Cancer Aimed at Targeting Cancer Cell Vulnerabilities

Myfanwy Jane Webb, Craig Kukard

Integrative Cancer Therapies Open Access

Published: Jan 2020
9 citations

1906 days before retraction

Immunohistochemical Analysis of mTOR Pathway-Related Proteins in Kaposiform Hemangioendothelioma

Zuopeng Wang, Chao Zheng, Hongqiang Sun et al. (7 authors)

Dermatology

Published: Jan 2020
15 citations

1906 days before retraction

TSN inhibits cell proliferation, migration, invasion, and EMT through regulating miR-874/HMGB2/β-catenin pathway in gastric cancer

Fanen Yuan, Zhijian Zhao, Bin Jia et al. (5 authors)

Neoplasma Open Access

Published: Jan 2020
12 citations

1906 days before retraction

An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer

Narges Dastmalchi, Reza Safaralizadeh, Behzad Baradaran et al. (5 authors)

Gene

Published: Dec 2019
37 citations

1912 days before retraction

Effect of Moxibustion on HIF-1α and VEGF Levels in Patients with Rheumatoid Arthritis

Yuanyuan Gong, Zeyun Yu, Yingni Wang et al. (12 authors)

Pain Research and Management Open Access

Published: Nov 2019
41 citations

1941 days before retraction

Metabolite profiling of traditional Chinese medicine XIAOPI formula: An integrated strategy based on UPLC-Q-Orbitrap MS combined with network pharmacology analysis

Neng Wang, Bowen Yang, Juping Zhang et al. (9 authors)

Biomedicine & Pharmacotherapy Open Access

Published: Nov 2019
17 citations

1953 days before retraction

Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia

Nalini Devarajan, Selvaraj Jayaraman, Senthil Kumar Ganesan

Journal of Cancer Research and Clinical Oncology

Published: Nov 2019
26 citations

1955 days before retraction

Danshen Improves Survival of Patients With Breast Cancer and Dihydroisotanshinone I Induces Ferroptosis and Apoptosis of Breast Cancer Cells

Yu‐Shih Lin, Yi-Chia Shen, Ching‐Yuan Wu et al. (20 authors)

Frontiers in Pharmacology Open Access

Published: Oct 2019
93 citations

1968 days before retraction

A network pharmacology approach to discover action mechanisms of Yangxinshi Tablet for improving energy metabolism in chronic ischemic heart failure

Ruoming Wu, Bing‐Hua Jiang, Hui Li et al. (8 authors)

Journal of Ethnopharmacology

Published: Sep 2019
37 citations

2021 days before retraction

Recent nanotechnological interventions targeting PI3K/Akt/mTOR pathway: A focus on breast cancer

Varruchi Sharma, Añil Sharma, Vasu Punj et al. (4 authors)

Seminars in Cancer Biology

Published: Aug 2019
67 citations

2050 days before retraction

Dual Effects of Chinese Herbal Medicines on Angiogenesis in Cancer and Ischemic Stroke Treatments: Role of HIF-1 Network

Ming Hong, Honglian Shi, Ning Wang et al. (6 authors)

Frontiers in Pharmacology Open Access

Published: Jun 2019
42 citations

2095 days before retraction

Related Records

This article has multiple records in the database due to different notices:

Record #64720

May 12, 2025

Correction

Quick Stats

Total Citations: 92

Years Since Retraction: <1 year

Open Access: Yes

Last Checked: Jul 23, 2025

Actions

More from this journal Similar subjects View Original Paper View Retraction Notice

Tanshinone IIA inhibits HIF-1α and VEGF expression in breast cancer cells via mTOR/p70S6K/RPS6/4E-BP1 signaling pathway

Paper Information

Institutions:

Country:

Retraction Details

Retraction Reasons:

Nature of Retraction:

Retraction Notice:

Citations (92)

92

1

90

1

Post-Retraction Citation Analysis

A study of zederone for the inhibition on ovarian cancer cell proliferation through mTOR/p70s6K signalling pathway.

Related Records

Quick Stats

Related Papers

Actions